International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

作者：Sarah K. Wise, Cecelia C. Damask, Lauren T. Roland, Charles S. Ebert, Joshua M. Levy, Sandra Y. Lin, Amber Luong, Kenneth Rodriguez, Ahmad R. Sedaghat, Elina M. Toskala, Jennifer A. Villwock, Baharudin Abdullah, Cezmi A. Akdiş, Jeremiah A. Alt, Ignacio Javier Ansotegui, Antoine Azar, Fuad M. Baroody, Michael S. Benninger, Jonathan A. Bernstein, Christopher D. Brook, Raewyn Gay Campbell, Thomas B. Casale, Mohamad R. Chaaban, Fook Tim Chew, Jeffrey Chambliss, Antonella Cianferoni, Adnan Čustović, Elizabeth Mahoney Davis, John M. DelGaudio, Anne K. Ellis, Carrie E. Flanagan, Wytske Johanna Fokkens, Christine B. Franzese, Matthew Greenhawt, Amarbir S. Gill, Ashleigh A. Halderman, Jens Michael Hohlfeld, Cristoforo Incorvaia, Stephanie A. Joe, Shyam R. Joshi, Merin Elizabeth Kuruvilla, Jean Kim, Adam M. Klein, Helene J. Krouse, Edward C. Kuan, David Michael Lang, Désirée E. Larenas‐Linnemann, Adrienne M. Laury, Matt Lechner, Stella E. Lee, Victoria S. Lee, Patricia Anne Loftus, Sonya Marcus, Haidy A. Marzouk, José L. Mattos, Edward D. McCoul, Erik Melén, James “Whit” Mims, Joaquim Mullol, Jayakar V. Nayak, John J Oppenheimer, Richard R. Orlandi, Katie M. Phillips, Michael P. Platt, Murugappan Ramanathan, Mallory J. Raymond, Chae‐Seo Rhee, Sietze Reitsma, Matthew W. Ryan, Joaquin Sastre, Rodney J. Schlosser, Theodore A. Schuman, Marcus S Shaker, Aziz Sheikh, Kristine A. Smith, Michael Soyka, Masayoshi Takashima, Monica C. Tang, Pongsakorn Tantilipikorn, Malcolm B. Taw, Jody R. Tversky, Matthew A. Tyler, Maria C. Veling, Dana V. Wallace, De Yun Wang, Andrew A. White, Luo Zhang · 发表于：International Forum of Allergy & Rhinology · 年份：2023 · DOI：10.1002/alr.23090 · 被引用次数：500 · 研究领域：Allergic Rhinitis and Sensitization、Sinusitis and nasal conditions、Respiratory and Cough-Related Research

BACKGROUND: In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR-Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR-Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence-based findings and recommendation from the full document. METHODS: ICAR-Allergic Rhinitis 2023 employed established evidence-based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. RESULTS: ICAR-Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. CONCLUSION: The ICAR-Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. I...